BioSymetrics software empowers healthcare and biomedical R&D innovation.
We created the first biomedical specific machine learning framework and programming language to increase precision, shorten timelines, and improve discovery.
The Augusta™ software platform significantly improves time-to-market and drives innovation. Augusta 2.0 enables data scientists to automate the tasks of pre-processing and management of disparate data, with integrated analysis, feature engineering, and predictive modeling in a single, easy-to-use framework.
Biopharma, Pharmaceutical, and CRO’s can rapidly leverage the power of AI and ML to enable lead compound discovery and trials. Easy to deploy, the Augusta™ framework enables faster pre-processing and model interrogation.
Utilize advanced artificial intelligence to classify subpopulations and tailor medical treatment to individual characteristics. The Augusta™ platform analyzes and draws inferences from vast amounts of data points, improving quality of patient care, enabling cost-effectiveness, reducing readmissions and mortality rates.
Hospitals, healthcare systems, and medical groups can improve institutional operations, finance and research programs. Applying machine learning (ML) to EMR’s, billing, admissions, radiology, cardiology, neurology, oncology and obstetrics (to name a few).
The AugustaTM platform allows rapid and effective integrated analytics and Machine Learning (ML) on many different kinds of biomedical and healthcare data types. Our AI ML platform capabilities include over 140 data modules that can be leveraged in data science and predictive analytics initiatives.
We offer turnkey services to our clients and corporate partners, with the aim of assisting organizations and teams in getting the greatest benefit from their data science initiatives. Our track record in massive data analytics including machine learning has been recognized with industry awards and conference speaking opportunities, and ties to our insight and knowledge base about the complexities in biomedical AI.
BioSymetrics services are available in several different ways, from our comprehensive technology solution implementations formalized in licensing agreements, to CRO consulting engagements and ad hoc projects.
Recent Blog Posts
A daughter’s desire to please her parents demonstrates how a data scientist with good intentions can cause far more harm and expense in the long run, through the selection and creation of the wrong features during data pre-processing.
Challenge: Combine Disparate Data Sets in PreProcessing for ML Summary: Compelling results show that combining data sources generally allowed better diagnostic performance than with any data set alone (Figures 1&2)
What is Contingent AI? In any data science pipeline there are a number of options that are selected for data processing (e.g. contrast settings for medical images, data imputation approaches,…
Advocate for healthcare technology innovation joins BioSymetrics in a mission to empower the application of AI within biomedicine. NEW YORK, February 7, 2019 (GLOBE NEWSWIRE) – BioSymetrics, an artificial intelligence…